REG - Morgan Stanley & Co. Oxford Biomedica PLC - Form 8.5 (EPT/RI) - Oxford Biomedica plc
26/02/2026 11:15
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260226:nRSZ5629Ua&default-theme=true
RNS Number : 5629U Morgan Stanley & Co. Int'l plc 26 February 2026
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED
INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Name of exempt principal trader: Morgan Stanley & Co. International plc
(b) Name of offeror/offeree in relation to whose relevant securities this form Oxford Biomedica plc
relates:
Use a separate form for each offeror/offeree
(c) Name of the party to the offer with which exempt principal trader is EQT Fund Management S.a.r.l.
connected:
(d) Date dealing undertaken: 25 February 2026
(e) In addition to the company in 1(b) above, is the exempt principal trader N/A
making disclosures in respect of any other party to this offer?
If it is a cash offer or possible cash offer, state "N/A"
2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security Purchases/ sales Total number of securities Highest price per unit paid/received Lowest price per unit paid/received
50p ordinary PURCHASES 431,193 6.8000 GBP 6.2459 GBP
50p ordinary SALES 443,227 6.8000 GBP 6.2879 GBP
50p ordinary SALES 20 8.6670 USD 8.6670 USD
(b) Cash-settled derivative transactions
Class of relevant security Product description Nature of dealing Number of reference securities Price per unit
e.g. CFD e.g. opening/closing a long/short position, increasing/reducing a long/short
position
50p ordinary CFD increasing a long position 58 6.3195 GBP
50p ordinary CFD increasing a long position 114 6.3196 GBP
50p ordinary CFD increasing a long position 4 6.3497 GBP
50p ordinary CFD increasing a long position 20 6.4000 GBP
50p ordinary CFD increasing a long position 8,455 6.4086 GBP
50p ordinary CFD increasing a long position 156 6.7577 GBP
50p ordinary CFD increasing a short position 15,761 6.2524 GBP
50p ordinary CFD increasing a short position 112 6.3199 GBP
50p ordinary CFD increasing a short position 1,654 6.3200 GBP
50p ordinary CFD increasing a short position 890 6.3200 GBP
50p ordinary CFD increasing a short position 32,168 6.3200 GBP
50p ordinary CFD increasing a short position 455 6.3768 GBP
50p ordinary CFD increasing a short position 3,535 6.4040 GBP
50p ordinary CFD increasing a short position 18,555 6.4373 GBP
50p ordinary CFD increasing a short position 1,786 6.4649 GBP
50p ordinary CFD increasing a short position 205 6.4713 GBP
50p ordinary CFD increasing a short position 133 6.4725 GBP
50p ordinary CFD increasing a short position 251 6.4944 GBP
50p ordinary CFD increasing a short position 4,144 6.6350 GBP
50p ordinary CFD increasing a short position 1,986 6.6350 GBP
50p ordinary CFD increasing a short position 2,468 6.6350 GBP
50p ordinary CFD increasing a short position 326 6.6350 GBP
50p ordinary CFD increasing a short position 1,076 6.6350 GBP
50p ordinary CFD increasing a short position 1,000 6.6400 GBP
50p ordinary CFD increasing a short position 27 6.6700 GBP
50p ordinary CFD reducing a long position 384 6.3200 GBP
50p ordinary CFD reducing a long position 936 6.3200 GBP
50p ordinary CFD reducing a long position 3,889 6.3200 GBP
50p ordinary CFD reducing a long position 2,410 6.3442 GBP
50p ordinary CFD reducing a long position 4,511 6.3768 GBP
50p ordinary CFD reducing a short position 48,241 6.3196 GBP
50p ordinary CFD reducing a short position 618 6.3289 GBP
50p ordinary CFD reducing a short position 354 6.3306 GBP
50p ordinary CFD reducing a short position 3 6.3733 GBP
50p ordinary CFD reducing a short position 15,761 6.3764 GBP
50p ordinary CFD reducing a short position 1,167 6.3831 GBP
50p ordinary CFD reducing a short position 1,973 6.3857 GBP
50p ordinary CFD reducing a short position 264 6.4139 GBP
50p ordinary CFD reducing a short position 339 6.4174 GBP
50p ordinary CFD reducing a short position 2,759 6.4242 GBP
50p ordinary CFD reducing a short position 18,555 6.4296 GBP
50p ordinary CFD reducing a short position 1,157 6.4418 GBP
50p ordinary CFD reducing a short position 4,000 6.6065 GBP
50p ordinary CFD reducing a short position 6,500 6.6202 GBP
50p ordinary CFD reducing a short position 400 6.6975 GBP
50p ordinary CFD reducing a short position 890 6.7349 GBP
50p ordinary CFD reducing a short position 1,444 6.7577 GBP
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type Expiry date Option money paid/ received per unit
e.g. American, European etc.
N/A N/A N/A N/A N/A N/A N/A N/A
(ii) Exercise
Class of relevant security Product description Exercising/ exercised against Number of securities Exercise price per unit
e.g. call option
N/A N/A N/A N/A N/A
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
N/A N/A N/A N/A
3. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the exempt
principal trader making the disclosure and any party to the offer or any
person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If
there are no such agreements, arrangements or understandings, state "none"
NONE
(b) Agreements, arrangements or understandings relating to
options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the exempt principal trader making the disclosure and any other person
relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
NONE
Date of disclosure: 26 February 2026
Contact name: Claire Gordon
Telephone number: +44 141 245-8893
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation
to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
(http://www.thetakeoverpanel.org.uk) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END FERTFMBTMTMTBPF
Copyright 2019 Regulatory News Service, all rights reservedRecent news on Oxford BioMedica
See all newsRCS - Oxford Biomedica PLC - Launch of viral vector fast-track offering
AnnouncementREG - Oxford Biomedica PLC - Grant of Awards
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights
AnnouncementREG - Oxford Biomedica PLC - 2026 Annual General Meeting notification
AnnouncementREG - Oxford Biomedica PLC - Preliminary results for the year ended 31 Dec 2025
Announcement